Commission Implementing Regulation (EU) 2023/216 of 1 February 2023 approving the low-risk active substance Trichoderma atroviride AGR2 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

Published date02 February 2023
Date of Signature01 February 2023
Official Gazette PublicationOfficial Journal of the European Union, L 030, 2 February 2023
Subject MatterPlant health legislation,Protocol on Ireland/Northern Ireland
L_2023030EN.01000701.xml
2.2.2023 EN Official Journal of the European Union L 30/7

COMMISSION IMPLEMENTING REGULATION (EU) 2023/216

of 1 February 2023

approving the low-risk active substance Trichoderma atroviride AGR2 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 13(2) in conjunction with Article 22(1) thereof,

Whereas:

(1) On 24 April 2018, France received an application pursuant to Article 7(1) of Regulation (EC) No 1107/2009 from Agrolor for the approval of the active substance Trichoderma atroviride AGR2.
(2) In accordance with Article 9(3) of that Regulation, France, as rapporteur Member State, notified the applicants, the other Member States, the Commission and the European Food Safety Authority (‘the Authority’) on 5 June 2018 of the admissibility of the application.
(3) On 23 June 2020, after assessing whether that active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009, rapporteur Member State submitted a draft assessment report to the Commission with a copy to the Authority.
(4) Pursuant to Article 12(1) of Regulation (EC) No 1107/2009, the Authority circulated the draft assessment report to the applicant and to other Member States.
(5) In accordance with Article 12(3) of Regulation (EC) No 1107/2009, it requested the applicant to supply additional information to the Member States, the Commission and the Authority.
(6) The assessment of the additional information by the rapporteur Member State was submitted to the Authority in the form of an updated draft assessment report.
(7) On 20 January 2022, the Authority communicated to the applicant, the Member States and the Commission its conclusion (2) on whether the active substance Trichoderma atroviride AGR2 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Authority made its conclusion available to the public.
(8) On 14 July 2022, the Commission presented a review report regarding Trichoderma atroviride AGR2 and a draft of this Regulation to the Standing Committee on Plants, Animals, Food and Feed.
(9) The Commission invited the applicant to submit its comments on the review report. The applicant submitted its comments, which have been carefully examined.
(10) It has been established, with respect to one representative use of at least one plant protection product containing the active substance, which was examined and detailed in the review report, that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
(11) The Commission further considers that Trichoderma atroviride AGR2 is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009. Trichoderma atroviride AGR2 is not a microorganism of concern and fulfils the conditions set in Annex II point 5.2 to Regulation (EC) No 1107/2009.
(12) It is therefore appropriate to approve Trichoderma atroviride AGR2 as a low-risk active substance.
(13) In accordance with Article 13(2) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge, it is necessary to include certain conditions.
(14) In accordance with Article 13(4) of Regulation (EC) No 1107/2009 in conjunction with Article 22(2) thereof,
...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT